Search Results - "Falloon J"

Indinavir concentrations and St John's wort [corrected] [published erratum appears in LANCET 2001 Apr 14; 357(9263): 1210].

Authors: Piscitelli SC Burstein AH Chaitt D et al.

Source: Lancet. 2/12/2000, Vol. 355 Issue 9203, p547-548. 2p.

A preliminary evaluation of 566C80 for the treatment of pneumocystis pneumonia in patients with...

Authors: Falloon, J. Kovacs, J.

Source: New England Journal of Medicine. 11/28/91, Vol. 325 Issue 22, p1534. 5p. 5 Charts, 1 Graph.

Look to the unlimed fields.

Authors: Falloon, J.

Source: Rock Products (1917); April 1956, Vol. 59, p84-84, 1p

Limestone's part in effective soil treatment.

Authors: Falloon, J.

Source: Rock Products (1917); May 1955, Vol. 58, p96-96, 1p

NIH conference. Recent advances in the management of AIDS-related opportunistic infections.

Authors: Lane, H C Laughon, B E Falloon, J et al.

Source: Annals of Internal Medicine. 6/1/94, Vol. 120 Issue 11, p945-955. 11p.

Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.

Authors: Whitcup, Scott M. Fortin, Eric Whitcup, S M et al.

Source: JAMA: Journal of the American Medical Association. 11/3/99, Vol. 282 Issue 17, p1633-1637. 5p.

Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet).

Authors: Polis, M A deSmet, M D Baird, B F et al.

Source: American Journal of Medicine. Feb1993, Vol. 94 Issue 2, p175-180. 6p.

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.

Authors: Lane, H C Davey, V Kovacs, J A et al.

Source: Annals of Internal Medicine. 6/1/90, Vol. 112 Issue 11, p805-811. 7p.

Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)

Authors: Kovacs, J A Deyton, L Davey, R et al.

Source: Annals of Internal Medicine. 8/15/89, Vol. 111 Issue 4, p280-287. 8p.

Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.

Authors: Lane, H. Clifford Falloon, Judith Walker, Robert E. et al.

Source: Annals of Internal Medicine. 7/1/89, Vol. 111 Issue 1, p41-50. 10p.

The pharmacokinetics of zidovudine administered by continuous infusion in children.

Authors: Balis, Frank M. Pizzo, Philip A. Murphy, Robert F. et al.

Source: Annals of Internal Medicine. 2/15/89, Vol. 110 Issue 4, p279-285. 7p.

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.

Authors: Kovacs JA Vogel S Albert JM et al.

Source: New England Journal of Medicine. 10/31/96, Vol. 335 Issue 18, p1350-1356. 7p.

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

Authors: Kovacs, Joseph A. Baseler, Michael Dewar, Robin J. et al.

Source: New England Journal of Medicine. 3/2/95, Vol. 332 Issue 9, p567-575. 9p.

Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults.

Authors: Ali, S.O. Yu, X.Q. Robbie, G.J. et al.

Source: Clinical Microbiology & Infection. May2019, Vol. 25 Issue 5, p629.e1-629.e6. 1p.

PARTIAL: study protocol for a clinical and cost-effectiveness of complex PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma randomised trial.

Authors: Johnson D Thomas R Cotton S et al.

Source: Trials [Trials] 2026 Mar 20; Vol. 27 (1). Date of Electronic Publication: 2026 Mar 20.

Publication Type: Journal Article; Clinical Trial Protocol

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

A Randomized Trial of Drug Route in Out-of-Hospital Cardiac Arrest.

Authors: Couper K Ji C Deakin CD et al.

Corporate Authors: Couper K Ji C Deakin CD et al.

Source: The New England journal of medicine [N Engl J Med] 2025 Jan 23; Vol. 392 (4), pp. 336-348. Date of Electronic Publication: 2024 Oct 31.

Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Comparative Study

Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine.

Authors: Chang LA Phung E Crank MC et al.

Source: Science translational medicine [Sci Transl Med] 2022 Dec 21; Vol. 14 (676), pp. eade0424. Date of Electronic Publication: 2022 Dec 21.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial.

Authors: Le Lay JE Du Q Mehta MB et al.

Source: Science translational medicine [Sci Transl Med] 2021 Apr 21; Vol. 13 (590).

Publication Type: Clinical Trial, Phase I; Journal Article

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.

Authors: Perugino C Culver EL Khosroshahi A et al.

Source: Rheumatology and therapy [Rheumatol Ther] 2023 Dec; Vol. 10 (6), pp. 1795-1808. Date of Electronic Publication: 2023 Oct 04.

Publication Type: Journal Article

Journal Info: Publisher: Springer Healthcare Country of Publication: England NLM ID: 101674543 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2198-6576 (Print) Linking ISSN: 21986576 NLM ISO Abbreviation: Rheumatol Ther Subsets: PubMed not MEDLINE

The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis.

Authors: Kivitz A Wang L Alevizos I et al.

Source: RMD open [RMD Open] 2023 Aug; Vol. 9 (3).

Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE